+499.5%
MRNA vs MOH
+18.1%
+481.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MOH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.2% | -2.1% |
| 7D | +5.5% | +0.4% | +5.1% | +5.4% |
| 30D | +158.7% | +2.9% | +155.8% | +157.0% |
| 3M | +182.1% | +4.1% | +178.0% | +179.6% |
| 6M | +151.8% | +33.8% | +118.0% | +135.5% |
| YTD | +393.6% | +15.7% | +377.8% | +369.1% |
| 1Y | +499.5% | +17.5% | +481.9% | +424.7% |
| All | +499.5% | +18.1% | +481.3% | +424.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MOH.
Daily Out/Under-Performance
Portfolio return minus MOH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MOH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MOH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling